Stay updated with breaking news from Jordan Leef. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Collaboration will strengthen and amplify identification of patients with Neurotrophic Tyrosine Receptor Kinase (NTRK) fusion-positive solid tumors potentially...
Published: Apr 14, 2021 Jeffrey Wasserman, JD, named General Counsel WALTHAM, Mass.--(BUSINESS WIRE)-- Pyramid Biosciences, Inc., a Boston-based, clinical-stage biotechnology company focused on developing new and highly differentiated precision therapies for cancer and other serious diseases, today announced two new appointments to the leadership team. Brian Lestini, MD, PhD, has joined the company as Chief Medical Officer, where he will oversee the advancement and expansion of the Company's clinical pipeline. Dr. Lestini joins the Company from Bristol-Myers Squibb (NYSE: BMY), wher...